Systemic delivery of glycosylated-PEG-masked oncolytic virus enhances targeting of antitumor immuno-virotherapy and modulates T and NK cell infiltration.
- Resource Type
- Article
- Source
- Theranostics; 2023, Vol. 13 Issue 15, p5452-5468, 17p
- Subject
- Language
- ISSN
- 18387640